Organovo Holdings is a biotechnology company that specializes in developing 3D tissues to replicate human disease. They use their proprietary NovoGen Bioprinters and related technology to create complex multicellular tissues. The company provides preclinical testing of drug compounds using their ExVive human liver and kidney tissue.